AT A GLANCE:

• Age-related hair loss and alopecia are extremely common—and often begin years before visible thinning appears.

• In many cases, hair follicles remain structurally intact but become inactive due to cellular aging and disrupted signaling.

• Regenerative approaches aim to restore follicle function by supporting the biology of the scalp, not just replacing hair.

• Banking your cells earlier also preserves future options as regenerative hair treatments continue to advance.

Aging brings plenty of surprises. While we often focus on larger health concerns, visible changes—like thinning hair or changes in our skin—are among the most common and emotionally impactful.

Research suggests that 16% of men between 18–29 already experience some degree of balding, rising to over 50% by midlife. Women are not immune: nearly half will experience noticeable hair thinning or loss over their lifetime. Beyond appearance, androgenetic alopecia has also been associated with increased rates of anxiety and depression, highlighting that hair loss is not just cosmetic—it’s deeply personal.1,2

And what’s often missing from the conversation is this: Hair loss is one of the earliest visible signs of cellular aging.

First Things First: What Different Kinds of Hair Loss Are There?

Not all hair loss is the same—and understanding which type you’re dealing with is essential when thinking about treatment, prevention, and long-term outcomes.

While aging plays a role in many forms of hair loss, the underlying biology can differ significantly.

Androgenetic Alopecia

Also known as Pattern Hair Loss, this is the most common form of hair loss in both men and women. It’s driven by genetic sensitivity to androgens (hormones) and changes in follicle signaling over time. Importantly, in androgenetic alopecia, hair follicles are often still present—they simply spend more time in a dormant state and produce thinner, weaker hairs. This makes it a key focus of regenerative research aimed at restoring follicle activity rather than replacing follicles entirely.3

Age-Related Diffuse Thinning

As we age, overall hair density can decrease across the scalp without a clear pattern. This type of thinning is often linked to:

• Reduced cellular turnover

• Chronic low-grade inflammation

• Declining regenerative signals

Hair grows more slowly, sheds more easily, and takes longer to recover—reflecting broader changes in cellular health.4

Telogen Effluvium

This form of hair loss is typically triggered by stressors such as illness, hormonal shifts, surgery, or significant life events. Hair follicles prematurely enter the resting phase, leading to noticeable shedding.

While often temporary, recovery can be slower with age as follicles become less resilient and regenerative signaling weakens.5

Alopecia Areata

In autoimmune forms of hair loss, the immune system mistakenly targets hair follicles. This can lead to patchy or widespread loss and often requires medical management.

Emerging regenerative research is exploring how modulating inflammation and improving cellular communication may support recovery alongside traditional treatments.6

Each type of hair loss reflects a different imbalance—hormonal, inflammatory, immune, or regenerative. That’s why modern approaches are shifting away from one-size-fits-all solutions toward strategies that support follicle health, cellular signaling, and long-term scalp biology.

Understanding your hair loss type is often the first step toward choosing the most effective path forward—today, and as regenerative options continue to evolve.

How Regenerative Approaches Are Changing Hair Loss Treatment

Traditional hair loss treatments tend to focus on slowing loss or redistributing existing hair. Regenerative approaches take a different path: they aim to restore the scalp environment that supports healthy hair growth. Some of them are also being leveraged to enhance existing treatment methods like transplants.

Rather than asking how to replace lost hair, regenerative research asks: Why did follicles stop producing healthy hair in the first place… and how can we support their ability to function again?

Early regenerative studies explored isolating and reintroducing hair follicle-associated cells into thinning areas, showing promising increases in hair density. More recent research has shifted toward understanding the cell signals that guide follicle behavior: growth factors, cytokines, and extracellular vesicles that influence inflammation, blood supply, and growth cycles.7

This evolution reflects a broader trend in longevity medicine: moving from structural fixes to biological repair.

Ready for the Next Era of Hair Regeneration? How Acorn Is Leading the Charge

Hair biology research has accelerated significantly over the past decade. We now understand the architecture of hair follicles far better than we did even a few years ago. Today’s most promising advances focus on helping existing follicles function better by improving the scalp environment that supports growth.

For the foreseeable future, many emerging approaches will prioritize:

• Improving follicle signaling
• Reducing chronic inflammation and senescent cellular behavior in the scalp
• Supporting longer, healthier growth phases (and faster recovery after shedding events)

In other words, the future of hair restoration is shifting from “replace what’s lost” to “restore what’s still there.” That shift makes early intervention more important than ever.

So how do you prepare for the next era of hair regeneration? You invest in your future self by banking your most regenerative cells via cryopreservation. These cells can be leveraged as a personalized secretome serum to couple with existing hair loss treatments, or as injections throughout your scalp to encourage healthier follicle behavior—but they can also be preserved for other hair loss advancements in the future.

Acorn offers a non-invasive approach to stem cell therapies through hair follicle collection, making it possible to preserve your own biology today—and support your hair and broader health in the future.

Explore if secretome is the right fit for you today.

–

FAQ

Q: Is age-related hair loss the same as alopecia?

A: Not always. Alopecia is an umbrella term that includes several types of hair loss. Some are age-related and gradual, while others are driven by immune, hormonal, or stress-related factors.

Q: Are hair follicles permanently gone when hair thins?

A: In many cases, no. Follicles often remain present but inactive, which is why regenerative approaches focus on restoring function rather than replacing hair entirely.

Q: How are regenerative hair treatments different than hair transplants?

A: Hair transplants relocate follicles from one area to another. Regenerative approaches aim to improve scalp biology and follicle signaling so existing hair can grow more effectively.

Q: Does aging affect how well hair treatments work?

A: Yes. As cells age, follicles may become less responsive to treatment. Earlier intervention generally offers more flexibility and better long-term outcomes.

Q: When should I start thinking about hair preservation?

A: Ideally before significant thinning occurs. Hair loss often begins at the cellular level years before it becomes visibly noticeable.

FURTHER READING:

1. Rhodes, T., Girman, C. J., Savin, R. C., Kaufman, K. D., Guo, S., Lilly, F. R., Siervogel, R. M., & Chumlea, W. C. (1998). Prevalence of male pattern hair loss in 18-49 year old men. Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.], 24(12), 1330–1332. https://doi.org/10.1111/j.1524-4725.1998.tb00009.x
2. Famenini, S., Slaught, C., Duan, L., & Goh, C. (2015). Demographics of women with female pattern hair loss and the effectiveness of spironolactone therapy. Journal of the American Academy of Dermatology, 73(4), 705–706. https://doi.org/10.1016/j.jaad.2015.06.063
3. Ho CH, Sood T, Zito PM. Androgenetic Alopecia. [Updated 2024 Jan 7]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430924/
4. Villani, A., Ferrillo, M., Fabbrocini, G., Ocampo-Garza, S. S., Scalvenzi, M., & Ruggiero, A. (2022). Hair Aging and Hair Disorders in Elderly Patients. International journal of trichology, 14(6), 191–196. https://doi.org/10.4103/ijt.ijt_90_21
5. Hughes EC, Syed HA, Saleh D. Telogen Effluvium. [Updated 2024 May 1]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK430848/
6. Lepe K, Syed HA, Zito PM. Alopecia Areata. [Updated 2024 Feb 8]. In: StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2025 Jan-. Available from: https://www.ncbi.nlm.nih.gov/books/NBK537000/
7. Legiawati, L., Sitohang, I. B. S., Yusharyahya, S. N., Sirait, S. P., Novianto, E., Liem, I. K., Kurniawati, T., Putri, I. S., Rahmadika, F. D., Hakiki, N. P., & Lauren, B. C. (2025). Hair regeneration in androgenetic alopecia using secretome of adipose-derived stem cells (ADSC) and minoxidil: a comparative study of three groups. Archives of dermatological research, 317(1), 486. https://doi.org/10.1007/s00403-025-04006-3
8. C.A. Higgins, J.C. Chen, J.E. Cerise, C.A.B. Jahoda, & A.M. Christiano, Microenvironmental reprogramming by three-dimensional culture enables dermal papilla cells to induce de novo human hair-follicle growth, Proc. Natl. Acad. Sci. U.S.A. 110 (49) 19679-19688, https://doi.org/10.1073/pnas.1309970110 (2013).